These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32441880)

  • 1. IUBMB focused meeting: 10
    Poznanski J; Fabbro D
    IUBMB Life; 2020 Jun; 72(6):1094-1096. PubMed ID: 32441880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proceedings of the 4th International Conference on Inhibitors of Protein Kinases and associated workshop: modelling of specific molecular recognition processes. June 25-29, 2005. Warsaw Poland.
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):1-331. PubMed ID: 16290080
    [No Abstract]   [Full Text] [Related]  

  • 3. IPK2019: David Shugar and the genesis of the IPK conferences.
    Pinna LA
    IUBMB Life; 2020 Jun; 72(6):1097-1102. PubMed ID: 32031322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights in protein kinase conformational dynamics.
    Saladino G; Gervasio FL
    Curr Top Med Chem; 2012; 12(17):1889-95. PubMed ID: 23116468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivalent inhibitors of protein kinases.
    Gower CM; Chang ME; Maly DJ
    Crit Rev Biochem Mol Biol; 2014; 49(2):102-15. PubMed ID: 24564382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling.
    Dar AC; Shokat KM
    Annu Rev Biochem; 2011; 80():769-95. PubMed ID: 21548788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods in Enzymology. Protein kinase inhibitors in research and medicine. Preface.
    Shokat KM
    Methods Enzymol; 2014; 548():xi-xii. PubMed ID: 25399648
    [No Abstract]   [Full Text] [Related]  

  • 8. DFGmodel: predicting protein kinase structures in inactive states for structure-based discovery of type-II inhibitors.
    Ung PM; Schlessinger A
    ACS Chem Biol; 2015 Jan; 10(1):269-78. PubMed ID: 25420233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule kinase inhibitors as anti-cancer therapeutics.
    Chahrour O; Cairns D; Omran Z
    Mini Rev Med Chem; 2012 May; 12(5):399-411. PubMed ID: 22303944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing the selectivity of kinase inhibitors in oncology: a chemical biology perspective.
    Maddox S; Hecht D; Gustafson JL
    Future Med Chem; 2016; 8(3):241-4. PubMed ID: 26898835
    [No Abstract]   [Full Text] [Related]  

  • 11. Unexpected off-targets and paradoxical pathway activation by kinase inhibitors.
    Hantschel O
    ACS Chem Biol; 2015 Jan; 10(1):234-45. PubMed ID: 25531586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors paradoxically prime kinases.
    Frye SV; Johnson GL
    Nat Chem Biol; 2009 Jul; 5(7):448-9. PubMed ID: 19465930
    [No Abstract]   [Full Text] [Related]  

  • 13. Strategies for the NMR-based identification and optimization of allosteric protein kinase inhibitors.
    Jahnke W; Blommers MJ; Fernández C; Zwingelstein C; Amstutz R
    Chembiochem; 2005 Sep; 6(9):1607-10. PubMed ID: 16028302
    [No Abstract]   [Full Text] [Related]  

  • 14. Multi-kinase inhibitors.
    Garuti L; Roberti M; Bottegoni G
    Curr Med Chem; 2015; 22(6):695-712. PubMed ID: 25511779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput kinase profiling as a platform for drug discovery.
    Goldstein DM; Gray NS; Zarrinkar PP
    Nat Rev Drug Discov; 2008 May; 7(5):391-7. PubMed ID: 18404149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced molecular dynamics simulation methods for kinase drug discovery.
    Aci-Sèche S; Ziada S; Braka A; Arora R; Bonnet P
    Future Med Chem; 2016 Apr; 8(5):545-66. PubMed ID: 27054816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
    Gyenis L; Turowec JP; Bretner M; Litchfield DW
    Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase inhibitors: narrowing down the real targets.
    Daub H
    Nat Chem Biol; 2010 Apr; 6(4):249-50. PubMed ID: 20300093
    [No Abstract]   [Full Text] [Related]  

  • 19. Irreversible protein kinase inhibitors: balancing the benefits and risks.
    Barf T; Kaptein A
    J Med Chem; 2012 Jul; 55(14):6243-62. PubMed ID: 22621397
    [No Abstract]   [Full Text] [Related]  

  • 20. Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors.
    Verkhivker GM
    Curr Med Chem; 2017; 24(42):4838-4872. PubMed ID: 27719654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.